Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Ocrevus helps Roche shrug off biosimilars in 2018

Ocrevus helps Roche shrug off biosimilars in 2018 cancer therapy Herceptin (trastuzumab) offset by gains of 14% in the US and 10% elsewhere. ... Roche said it thinks the same pattern will be evident this year, however, with new product growth outweighing declines for MabThera, Herceptin and Avastin

Hardy returns to Genentech as CEO

Hardy returns to Genentech as CEO mid-June for a launch date as Herceptin is still protected by patent laws. ... It’s a slightly different story for the EU however, where Ontruzant became the first Herceptin biosimilar to be approved in late 2017, closely followed by several others.

Roche’s new flu pill Xofluza approved in US

Roche’s new flu pill Xofluza approved in US Roche is in need of a new set of innovative products, as its older generation of blockbusters, Avastin, Herceptin and MabThera/Rituxan come under competition from biosimilars.

Roche preps new Kadcyla filings after phase 3 trial win

Roche preps new Kadcyla filings after phase 3 trial win evidence that giving it in place of Herceptin would actually make patients less likely to relapse. ... That will help support the $10bn-plus franchise as Herceptin faces the threat of biosimilar competition in some European markets, including the UK.

Ocrevus surge keeps Roche smiling in Q3

Ocrevus surge keeps Roche smiling in Q3 As expected, biosimilar competition to two of its top products – MabThera and Herceptin – weighed heavy on Roche in the third quarter in Europe. ... Meanwhile, breast cancer therapy Herceptin (trastuzumab) also continued its European decline thanks

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...
Spotlight interview: 15 minutes on Independent Medical Education
Celeste Kolanko, Managing Director of Liberum, OPEN Health takes 15 minutes to answer some key questions on independent medical education....

Infographics